Oncogenic osteomalacia: Two case reports with surprisingly different outcomes

Archives of Orthopaedic and Trauma Surgery

Volumn 129, Issue 4, 2009, Pages 533-539

  Seijas, Roberto ^a   Ares, Oscar ^a   Sierra, Judit ^b   Pérez Dominguez, Manuel ^b  

^a HOSPITAL QUIRÓN   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Fibroblast growth factor; Hypophosphatemia; Mesenchymal tumor; Osteomalacia

Indexed keywords

ANALGESIC AGENT; CALCITRIOL; CALCIUM; COLECALCIFEROL; DOXORUBICIN; GABAPENTIN; IMATINIB; OCTREOTIDE; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ADULT; ARTICLE; BONE DENSITY; BONE METASTASIS; BONE SCINTISCANNING; BREAST TUMOR; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMANGIOPERICYTOMA; HIP RADIOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIC RICKETS; LABORATORY TEST; LIVER CANCER; LIVER METASTASIS; MALE; MESENCHYMOMA; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENIC OSTEOMALACIA; ORTHOPEDIC SURGERY; OSTEOPOROSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SIDE EFFECT; SOFT TISSUE SARCOMA; SPINAL CORD SURGERY; SPINAL CORD TUMOR; VITAMIN BLOOD LEVEL;

ADULT; BONE NEOPLASMS; FATAL OUTCOME; FEMALE; FEMORAL NEOPLASMS; FOOT DISEASES; HEMANGIOPERICYTOMA; HIP FRACTURES; HUMANS; HYPOPHOSPHATEMIA; INDIUM RADIOISOTOPES; LIVER NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASMS, CONNECTIVE TISSUE; OCTREOTIDE; OSTEOMALACIA; PARANEOPLASTIC SYNDROMES; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 62749092034     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-008-0808-2     Document Type: Article

References (17)

1. Braunwald E, Fauci AS, Dennis LK, Hauser SL, Longo DL, Jameson JL (2002) Principios de medicina interna, 15th edn. McGraw-Hill, Madrid, p 2568, pp 2574-2576
2. Carpenter TO (2003) Oncogenic osteomalacia: A complex dance of factors [editorial]. N Engl J Med 348(17):1705-1708
3. Cheung FM, Ma L, Wu WC, Siu TH, Choi PT, Tai YP (2006) Oncogenic osteomalacia associated with an occult phosphaturic mesenchymal tumour: clinico-radiologico-pathological correlation and ultrastructural studies. Hong Kong Med J 12(4):319-321
4. Felig P, Frohman LA (2001) Endocrinology and metabolism, 4th edn. McGraw-Hill, New York, pp 1409-1423
5. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M et al (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28(1):1-30
6. Huang QL, Feig DS, Blackstein ME (2000) Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia. J Endocrinol Invest 23(4):263
7. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348(17):1656-1663
8. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (2003) Endocrinology, 10th edn. Saunders, Philadelphia, pp 1349-1351, 1393-1395 and 1847
9. Park YK, Unni KK, Beabout JW, Hodgson SF (1994) Oncogenic osteomalacia: a clinicopathologic study of 17 bone lesions. J Korean Med Sci 9(4):289-298
10. Seufert J, Ebert K, Müller J et al (2001) Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345:1883-1888
11. Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL (1997) Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res 12(9):1502-1511
12. Stewart I, Roddie C, Gill A, Clarkson A, Mirams M, Coyle L, Ward C, Clifton-Bligh P, Robinson BG, Mason RS, Clifton-Bligh RJ (2006) Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone 39(2):369-376
13. Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP (2006) Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: A case report. G Chir 27(1-2):9-13
14. Weidner N, Bar RS, Weiss D, Strottmann P (1985) Neoplastic pathology of oncogenic osteomalacia/rickets. Cancer 55:1691-1705
15. Weidner N, Santa Cruz D (1987) Phosphaturic mesenchymal tumors: A polymorphous group causing osteomalacia or rickets. Cancer 59:1442-1454
16. Yeung SJ, McCutcheon IE, Schultz P, Gagel RF (2000) Use of long-term intravenous phosphate infusion in the palliative treatment of tumor-induced osteomalacia. J Clin Endocrinol Metab 85(2):549-555
17. Zimering MB, Caldarella FA, White KE, Econs MJ (2005) Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes. Endocr Pract 11(2):108-114